Login / Signup
Heartbeat: Questionable benefit of beta-blocker therapy more than one year after myocardial infarction in patients without heart failure or ventricular dysfunction.
Catherine M Otto
Published in:
Heart (British Cardiac Society) (2023)
Keyphrases
</>
heart failure
end stage renal disease
ejection fraction
chronic kidney disease
left ventricular
newly diagnosed
oxidative stress
atrial fibrillation
stem cells
patient reported outcomes
bone marrow
patient reported